All Stories

  1. Bioactive peptoids against vector-borne parasitic diseases
  2. Molecular diagnostics for cutaneous leishmaniasis: progress towards fulfilling the WHO target product profile
  3. INTERACT: Interactome Network Targeting via Enzyme Reactivity and Activity-based Chemoproteomic Tools
  4. Profiling Serine Hydrolases in the Leishmania Host–Pathogen Interactome Using Cell‐Permeable Activity‐Based Fluorophosphonate Probes
  5. Nanostructured Lipid Carrier for Intracellular Delivery of a Bis(pyridine-2-carboxamidine) DNA Minor Groove Binder Active against Leishmania
  6. Simple accessible clemastine fumarate analogues as effective antileishmanials
  7. BONCAT-iTRAQ Labelling Reveals Molecular Markers of Adaptive Responses in Toxoplasma gondii to Pyrimethamine Treatment
  8. Evaluation of the Leishmania Inositol Phosphorylceramide Synthase as a Drug Target Using a Chemical and Genetic Approach
  9. Rapid genotyping of Toxoplasma gondii isolates via Nanopore-based multi-locus sequencing
  10. Clemastine/tamoxifen hybrids as easily accessible antileishmanial drug leads
  11. Inhibition of HSP90 distinctively modulates the global phosphoproteome of Leishmania mexicana developmental stages
  12. Toxoplasma ceramide synthases: Gene duplication, functional divergence, and roles in parasite fitness
  13. Disruption of the inositol phosphorylceramide synthase gene affects Trypanosoma cruzi differentiation and infection capacity
  14. Assessment of Toxoplasma gondii lytic cycle and the impact of a gene deletion using 3D label-free optical diffraction holotomography
  15. Inhibition of HSP90 distinctively modulates the global phosphoproteome of Leishmania mexicana developmental stages
  16. Editorial: Leishmania genome variability: Impacts on parasite evolution, parasitism and leishmaniases control
  17. Amphotericin B resistance in Leishmania mexicana: Alterations to sterol metabolism and oxidative stress response
  18. Genome deletions to overcome the directed loss of gene function in Leishmania
  19. Illuminating Host-Parasite Interaction at the Cellular and Subcellular Levels with Infrared Microspectroscopy
  20. Transcriptome-Wide Identification of Coding and Noncoding RNA-Binding Proteins Defines the Comprehensive RNA Interactome of Leishmania mexicana
  21. Toxoplasma ceramide synthases: a curious case of gene duplication, divergence and key functionality
  22. The Histidine Ammonia Lyase of Trypanosoma cruzi Is Involved in Acidocalcisome Alkalinization and Is Essential for Survival under Starvation Conditions
  23. Transcriptome-wide identification of coding and noncoding RNA-binding proteins defines the comprehensive RNA interactome of Leishmania mexicana
  24. Amphotericin B resistance in Leishmania mexicana : Alterations to sterol metabolism, lipid transport and oxidative stress response
  25. Chalcones identify cTXNPx as a potential antileishmanial drug target
  26. Quantitative Proteomics Reveals that Hsp90 Inhibition Dynamically Regulates Global Protein Synthesis in Leishmania mexicana
  27. Antileishmanial Chemotherapy through Clemastine Fumarate Mediated Inhibition of the Leishmania Inositol Phosphorylceramide Synthase
  28. How can proteomics overhaul our understanding of Leishmania biology?
  29. Apoptotic blebs from Leishmania major-infected macrophages as a new approach for cutaneous leishmaniasis vaccination
  30. An investigation of the antileishmanial properties of semi-synthetic saponins
  31. A BONCAT-iTRAQ method enables temporally resolved quantitative profiling of newly synthesised proteins in Leishmania mexicana parasites during starvation
  32. Mining for natural product antileishmanials in a fungal extract library
  33. A BONCAT-iTRAQ method enables temporally resolved quantitative profiling of newly synthesised proteins in Leishmania mexicana parasites during starvation
  34. The identification of small molecule inhibitors of the plant inositol phosphorylceramide synthase which demonstrate herbicidal activity
  35. Expression levels of inositol phosphorylceramide synthase modulate plant responses to biotic and abiotic stress in Arabidopsis thaliana
  36. Lytic reactions of drugs with lipid membranes
  37. Tamoxifen inhibits the biosynthesis of inositolphosphorylceramide in Leishmania
  38. Yeast: bridging the gap between phenotypic and biochemical assays for high-throughput screening
  39. Functional Analyses of a Putative, Membrane-Bound, Peroxisomal Protein Import Mechanism from the Apicomplexan Protozoan Toxoplasma gondii
  40. Identifying inhibitors of the Leishmania inositol phosphorylceramide synthase with antiprotozoal activity using a yeast-based assay and ultra-high throughput screening platform
  41. Complex Interplay between Sphingolipid and Sterol Metabolism Revealed by Perturbations to the Leishmania Metabolome Caused by Miltefosine
  42. Microbial protein targets: towards understanding and intervention
  43. Repurposing as a strategy for the discovery of new anti-leishmanials: the-state-of-the-art
  44. Functional and phylogenetic evidence of a bacterial origin for the first enzyme in sphingolipid biosynthesis in a phylum of eukaryotic protozoan parasites
  45. Everybody needs sphingolipids, right! Mining for new drug targets in protozoan sphingolipid biosynthesis
  46. The antifungal Aureobasidin A and an analogue are active against the protozoan parasite Toxoplasma gondii but do not inhibit sphingolipid biosynthesis – Corrigendum
  47. The antifungal Aureobasidin A and an analogue are active against the protozoan parasite Toxoplasma gondii but do not inhibit sphingolipid biosynthesis
  48. An Efficient Method for the Synthesis of Peptoids with Mixed Lysine-type/Arginine-type Monomers and Evaluation of Their Anti-leishmanial Activity
  49. Enlarging the chemical space of anti-leishmanials: a structure–activity relationship study of peptoids against Leishmania mexicana, a causative agent of cutaneous leishmaniasis
  50. Crystal Structure of a Hidden Protein, YcaC, a Putative Cysteine Hydrolase from Pseudomonas aeruginosa, with and without an Acrylamide Adduct
  51. The Role of Phosphoglycans in the Susceptibility of Leishmania mexicana to the Temporin Family of Anti-Microbial Peptides
  52. Yeast as a Potential Vehicle for Neglected Tropical Disease Drug Discovery
  53. Investigating the Anti‐leishmanial Effects of Linear Peptoids
  54. The utility of yeast as a tool for cell-based, target-directed high-throughput screening
  55. Aqueous synthesis of N,S-dialkylthiophosphoramidates: design, optimisation and application to library construction and antileishmanial testing
  56. Sphingolipid synthesis and scavenging in the intracellular apicomplexan parasite, Toxoplasma gondii
  57. Endocytosis and Sphingolipid Scavenging inLeishmania mexicanaAmastigotes
  58. Lipid Metabolism as a Therapeutic Target
  59. Sphingolipid and Ceramide Homeostasis: Potential Therapeutic Targets
  60. Studies on the antileishmanial properties of the antimicrobial peptides temporin A, B and 1Sa
  61. Exploring Leishmania major Inositol Phosphorylceramide Synthase (LmjIPCS): Insights into the ceramide binding domain
  62. A plate-based assay system for analyses and screening of the Leishmania major inositol phosphorylceramide synthase
  63. Functional analyses of differentially expressed isoforms of the Arabidopsis inositol phosphorylceramide synthase
  64. The Trypanosoma brucei sphingolipid synthase, an essential enzyme and drug target
  65. The Protozoan Inositol Phosphorylceramide Synthase
  66. An Evolutionarily Conserved Coiled-Coil Protein Implicated in Polycystic Kidney Disease Is Involved in Basal Body Duplication and Flagellar Biogenesis in Trypanosoma brucei
  67. Direct transport across the plasma membrane of mammalian cells ofLeishmaniaHASPB as revealed by a CHO export mutant
  68. Leishmania major: clathrin and adaptin complexes of an intra-cellular parasite
  69. Rafts and sphingolipid biosynthesis in the kinetoplastid parasitic protozoa
  70. Sphingolipid‐free Leishmania are defective in membrane trafficking, differentiation and infectivity
  71. Ether Phospholipids and Glycosylinositolphospholipids Are Not Required for Amastigote Virulence or for Inhibition of Macrophage Activation by Leishmania major
  72. The endocytic apparatus of the kinetoplastida. Part II: machinery and components of the system
  73. The kinetoplastida endocytic apparatus. Part I: a dynamic system for nutrition and evasion of host defences
  74. Leishmania RAB7: characterisation of terminal endocytic stages in an intracellular parasite
  75. Phenotypic changes associated with deletion and overexpression of a stage-regulated gene family in Leishmania
  76. Meeting Report: Molecular Parasitology XI, Woods Hole, USA, September 17–21, 2000
  77. GPI-anchored proteins and glycoconjugates segregate into lipid rafts in Kinetoplastida
  78. The in vivo conformation of the plastid DNA of Toxoplasma gondii: implications for replication11Edited by N.-H. Chua
  79. DRMs, secretion and lipid architecture in Trypanosomatidae
  80. Expression of the AM gene locus in infective stages of Leishmania
  81. Acylation-dependent Protein Export in Leishmania
  82. Evidence for a Single Origin of the 35 kb Plastid DNA in Apicomplexans
  83. Thiostrepton binds to malarial plastid rRNA
  84. A Plastid of Probable Green Algal Origin in Apicomplexan Parasites
  85. Complete Gene Map of the Plastid-like DNA of the Malaria ParasitePlasmodium falciparum